Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Zao Ranbaxy, a prominent player in the pharmaceutical industry, is headquartered in Russia (RU) and operates extensively across various regions. Founded in 1993, the company has established itself as a key provider of generic and branded medications, focusing on therapeutic areas such as cardiovascular, anti-infective, and gastrointestinal health.
With a commitment to quality and innovation, Zao Ranbaxy offers a diverse portfolio of products that cater to the evolving needs of healthcare professionals and patients alike. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. Renowned for its rigorous quality standards and competitive pricing, Zao Ranbaxy continues to strengthen its position in the pharmaceutical landscape, contributing to improved health outcomes across Russia and beyond.
35
DitchCarbon score
Part of the Sustainability team at Zao Ranbaxy, Russia?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Reported emissions
No reported emissions data is available for Zao Ranbaxy, Russia yet.
Zao Ranbaxy, Russia's reported carbon emissions
Zao Ranbaxy, based in Russia, currently does not report specific carbon emissions data, as indicated by the absence of available figures. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate strategies and reporting practices.
As of now, Zao Ranbaxy has not established any documented reduction targets or climate pledges. This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
Given its affiliation with Sun Pharmaceutical Industries Limited, emissions data and climate initiatives may be cascaded from this parent company. However, no specific emissions figures or reduction targets from Sun Pharmaceutical Industries Limited have been provided for Zao Ranbaxy at this time.
In summary, Zao Ranbaxy's current climate commitments and emissions data remain unspecified, reflecting a potential area for future development in sustainability practices.
Assessing Zao Ranbaxy, Russia as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Zao Ranbaxy, Russia and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Zao Ranbaxy, Russia’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Zao Ranbaxy, Russia yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Inherited from Sun Pharmaceutical Industries LimitedSign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Zao Ranbaxy, Russia yet.
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more